SPOTLIGHT -
EP. 1: Diagnosis of Neurofibromatosis Type 1
EP. 2: Overview of Plexiform Neurofibromas in NF1
EP. 3: Management of Plexiform Neurofibromas in NF1
EP. 4: Disease Burden of NF1 with PNs
EP. 5: Therapeutic Options for NF1 With PNs
EP. 6: Managing Symptoms of NF1
EP. 7: Treatment of NF1 With PNs: MEK Inhibition
EP. 8: SPRINT Trial: NF1 With PNs
EP. 9: NF1 With PNs: Future of Treatment With MEK Inhibitors
EP. 10: Unmet Needs in the Management of NF1 With PNs
Dr Berkenstock on ADC-Related Ocular Toxicities in Cervical and Ovarian Cancers
Dr Matalonis on the Management of Mirvetuximab Soravtansine-Related Toxicities in FRα+ Ovarian Cancer
Updated EMPOWER-Lung 3 Data Support Frontline Cemiplimab Plus Chemo in Advanced NSCLC
Neoadjuvant Nivolumab Plus Chemotherapy Retains EFS Advantage in Resectable NSCLC